Target Name: LOC100130331
NCBI ID: G100130331
Other Name(s): POTE ankyrin domain family, member F pseudogene

LOC100130331: A Drug Target / Disease Biomarker

LOC100130331 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the LOC1001 family of proteins, which are known to play a role in cell signaling. LOC100130331 has been shown to interact with several different proteins, including the protein p21 (also known as PD-L1), which is a negative regulator of the immune response.

One of the most promising aspects of LOC100130331 is its potential as a drug target. The ability of this protein to interact with p21 suggests that it may be a good candidate for inhibition, either alone or in combination with other treatments. This protein could potentially be used to treat a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

In addition to its potential as a drug target, LOC100130331 has also been shown to be a potential biomarker. The ability of this protein to interact with p21 suggests that it may be a useful indicator of the activity of the immune system. This could be useful for the development of new treatments for autoimmune disorders, where the immune system attacks the body's own tissues.

LOC100130331 has also been shown to play a role in several different cellular processes, including cell signaling, cell division, and protein synthesis. It is a component of the endoplasmic reticulum, which is the system responsible for transporting and modifying proteins before they are released into the cytoplasm. It is also involved in the regulation of gene expression, which is the process by which the instructions in a cell's DNA are used to build the proteins that make up the cell.

In conclusion, LOC100130331 is a protein that has the potential to be a drug target or biomarker. Its ability to interact with p21 and its involvement in cellular processes suggest that it may be a useful tool for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of LOC100130331 in the immune system and its potential as a drug or biomarker.

Protein Name: POTE Ankyrin Domain Family, Member F Pseudogene

More Common Targets

LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023